Cite
Rectovaginal extragastrointestinal stromal tumour (EGIST): an additional entity to be considered in the differential diagnosis of tumours of the rectovaginal septum
MLA
Catherine Johnson, et al. “Rectovaginal Extragastrointestinal Stromal Tumour (EGIST): An Additional Entity to Be Considered in the Differential Diagnosis of Tumours of the Rectovaginal Septum.” BMJ Case Reports, vol. 14, no. 3, Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9941ad7d5d2ae6ccc7469f01958c168e&authtype=sso&custid=ns315887.
APA
Catherine Johnson, M Alazzam, Hooman Soleymani Majd, & Susan Addley. (2023). Rectovaginal extragastrointestinal stromal tumour (EGIST): an additional entity to be considered in the differential diagnosis of tumours of the rectovaginal septum. BMJ Case Reports, 14(3).
Chicago
Catherine Johnson, M Alazzam, Hooman Soleymani Majd, and Susan Addley. 2023. “Rectovaginal Extragastrointestinal Stromal Tumour (EGIST): An Additional Entity to Be Considered in the Differential Diagnosis of Tumours of the Rectovaginal Septum.” BMJ Case Reports 14 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9941ad7d5d2ae6ccc7469f01958c168e&authtype=sso&custid=ns315887.